Antiretroviral treatment roll-out policy is in place - now for the implementation challenges by Ncayiyana, Daniel J
To the country’s collective sigh of relief, the South African
government announced on 8 August 2003 that it would provide
anti-AIDS drugs free of charge in the public sector, thereby
putting an end to years of controversy marked by court battles
and other forms of confrontation with the Treatment Action
Campaign, the South African Medical Association and other civil
society formations. 
And on 20 November 2003, the Cabinet approved the
‘Operational Plan for the Comprehensive Treatment and Care for
HIV and AIDS’ (the Plan) prepared by the Department of
Health. In this well-considered plan, the provision of
antiretroviral (ARV) treatment in the public sector is but one of a
number of strategies to deal with the HIV and AIDS epidemic.
The Plan proposes designated HIV and AIDS service points
across the country, and envisages that, within a year, there will
be at least one service point in every health district (there are 56
health districts altogether) and within 5 years, one in every
municipality. ‘Some areas will be able to start sooner than others,
and the Department of Health will keep the public informed of
the progress of the rollout’ according to Minister Manto
Tshabalala-Msimang.
The government is quite rightly determined that the provision
of ARV treatment does not detract from the broader campaign
against the HIV/AIDS pandemic.  Other elements of the plan
therefore include ‘stepping up the prevention campaign so that
the 40 million South Africans not infected stay that way;
improved efforts in treating opportunistic infections for those
who are infected but have not reached the stage at which they
require ARVs, and intensified support for families affected by
HIV and AIDS’. A potentially controversial proposal is to
‘expand programmes aimed at boosting the immune system and
slowing down the effects of HIV infection, including the option
of traditional health treatments for those who use these services’.
There is currently an unprecedented local and global focus on
the funding of ARV treatment to AIDS victims on the African
continent. The World Health Organisation’s ‘3 by 5 Initiative’
seeks to get ARVs to 3 million AIDS sufferers in the developing
world by 2005, while the Clinton Foundation HIV/AIDS
Initiative intends to provide treatment to as many as 2 million
people in Rwanda, South Africa, Mozambique, Tanzania and the
Caribbean by the year 2008. The Canadian government and the
US Bush administration have both pledged significant resources
in this regard. Here at home, SAMA has launched its own
treatment programme, called the Tshepang Campaign, and the
government plans ultimately to devote 11.5% of current public
sector health spending — an equivalent of US$687 — to the
programme by 2007.
One of a kind
The envisaged South African ARV treatment programme will be
the largest in the world, without precedent in its sheer size and
scope. In no other country has a universal AIDS treatment
programme involving the sort of numbers we are talking about
in the Plan been attempted.  In Zambia, only 7 000 people are
currently receiving drug treatment, with plans to increase this
number to 10 000. Malawi recently unveiled plans to provide
treatment for up to 50 000 people, using a grant from the Global
Fund.
This column has previously underscored the mammoth
logistical and human capacity challenges confronting the
implementation of an ARV treatment programme of the
magnitude envisaged for South Africa. These include the
prerequisite to train appropriate staff — counsellors, social
workers, nurses and doctors; the need to ensure the reliable
supply and the secure local storage of specialised drugs; the
need for access to essential laboratory monitoring; the challenge
of ensuring the reliable tracking of possibly millions of patients
under treatment; the threat of non-compliance and treatment
interruption leading to widespread drug resistance; and so forth.
A news item on the Health Systems Trust website dated 19
December 2003 observed that ‘despite the government’s decision
to roll out the provision of ARVs, a lack of planning has meant
temporary [drug] shortages — and could presage future crises if
problems are not dealt with. An interruption in ARV treatment
could have serious health consequences for people on a
programme of treatment. Inconsistent supply of ARVs could kill
[patients] sooner than the disease itself.’
The Plan has anticipated these potential difficulties. The final
draft drawn up by the department’s ARV task team has set aside
a significant portion of funds for the training of thousands of
nurses, doctors, laboratory technicians, counsellors and other
health workers.
The place of nutrition in the management of people living
with AIDS has been the subject of some controversy in South
Africa, where some voices were understood to be advocating it
as the sole remedy. There is general agreement, however, that
good nutrition has an important role to play in the prevention
and management of HIV and AIDS, as with any other serious
illness. In this regard, Lucy Steinitz of Namibia’s Catholic AIDS
Action has expressed concern about the region’s drought and
food shortages affecting more than 6.5 million people that, she
says, will make the task of managing AIDS even more difficult. 
The controversies over the government’s position on the
causation of AIDS have served to obscure South Africa’s gains of
the last few years in the fight against HIV, including the
successful campaign for affordable
ARV prices in the region. 
The implementation challenges
notwithstanding, and given the
worldwide scorn we have had to
endure over the last few years, the
Plan represents a bold and
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